These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 36822117)

  • 1. Bovine serum albumin-based and dual-responsive targeted hollow mesoporous silica nanoparticles for breast cancer therapy.
    Zhang Y; Ye Z; He R; Li Y; Xiong B; Yi M; Chen Y; Liu J; Lu B
    Colloids Surf B Biointerfaces; 2023 Apr; 224():113201. PubMed ID: 36822117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Albumin-MnO
    Fang J; Wang Q; Yang G; Xiao X; Li L; Yu T
    Colloids Surf B Biointerfaces; 2019 Jul; 179():250-259. PubMed ID: 30978612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fabrication of folic acid-modified bovine serum albumin cloaked dual-drug loaded hollow mesoporous silica nanoparticles for pH-responsive and targeted delivery of gastric cancer therapy.
    Zhang Y; Liang Y
    Heliyon; 2024 Apr; 10(8):e29274. PubMed ID: 38699737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fabricating polydopamine-coated MoSe
    Chai S; Kan S; Sun R; Zhou R; Sun Y; Chen W; Yu B
    Int J Nanomedicine; 2018; 13():7607-7621. PubMed ID: 30510420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyaluronic acid targeted and pH-responsive nanocarriers based on hollow mesoporous silica nanoparticles for chemo-photodynamic combination therapy.
    Chen K; Chang C; Liu Z; Zhou Y; Xu Q; Li C; Huang Z; Xu H; Xu P; Lu B
    Colloids Surf B Biointerfaces; 2020 Oct; 194():111166. PubMed ID: 32521461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-stimuli responsive mesoporous silica-coated carbon nanoparticles for chemo-photothermal therapy of tumor.
    Lu H; Zhao Q; Wang X; Mao Y; Chen C; Gao Y; Sun C; Wang S
    Colloids Surf B Biointerfaces; 2020 Jun; 190():110941. PubMed ID: 32169778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hollow Mesoporous Silica Nanoparticles Gated by Chitosan-Copper Sulfide Composites as Theranostic Agents for the Treatment of Breast Cancer.
    Niu S; Zhang X; Williams GR; Wu J; Gao F; Fu Z; Chen X; Lu S; Zhu LM
    Acta Biomater; 2021 May; 126():408-420. PubMed ID: 33731303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. pH-sensitive Au-BSA-DOX-FA nanocomposites for combined CT imaging and targeted drug delivery.
    Huang H; Yang DP; Liu M; Wang X; Zhang Z; Zhou G; Liu W; Cao Y; Zhang WJ; Wang X
    Int J Nanomedicine; 2017; 12():2829-2843. PubMed ID: 28435261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aerosol technique-based carbon-encapsulated hollow mesoporous silica nanoparticles for synergistic chemo-photothermal therapy.
    Gautam M; Thapa RK; Poudel BK; Gupta B; Ruttala HB; Nguyen HT; Soe ZC; Ou W; Poudel K; Choi HG; Ku SK; Yong CS; Kim JO
    Acta Biomater; 2019 Apr; 88():448-461. PubMed ID: 30818051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
    Ma X; Zhao Y; Ng KW; Zhao Y
    Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chitosan capped pH-responsive hollow mesoporous silica nanoparticles for targeted chemo-photo combination therapy.
    Yan T; He J; Liu R; Liu Z; Cheng J
    Carbohydr Polym; 2020 Mar; 231():115706. PubMed ID: 31888831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coordination-Accelerated "Iron Extraction" Enables Fast Biodegradation of Mesoporous Silica-Based Hollow Nanoparticles.
    Wang L; Huo M; Chen Y; Shi J
    Adv Healthc Mater; 2017 Nov; 6(22):. PubMed ID: 28941142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dual-sensitive mesoporous silica nanoparticle based drug carrier for cancer synergetic therapy.
    Zhang J; Shen B; Chen L; Chen L; Meng Y; Feng J
    Colloids Surf B Biointerfaces; 2019 Mar; 175():65-72. PubMed ID: 30522009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI-guided dual-responsive anti-tumor nanostructures for synergistic chemo-photothermal therapy and chemodynamic therapy.
    Shi Y; Zhou M; Zhang Y; Wang Y; Cheng J
    Acta Biomater; 2023 Mar; 158():571-582. PubMed ID: 36586501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction and performance evaluation of pH-responsive oxidized hyaluronic acid hollow mesoporous silica nanoparticles.
    Enyu X; Xinbo L; Xuelian C; Huimin C; Yin C; Yan C
    Int J Biol Macromol; 2024 Feb; 257(Pt 1):128656. PubMed ID: 38065461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Albumin-bioinspired iridium oxide nanoplatform with high photothermal conversion efficiency for synergistic chemo-photothermal of osteosarcoma.
    Gu W; Zhang T; Gao J; Wang Y; Li D; Zhao Z; Jiang B; Dong Z; Liu H
    Drug Deliv; 2019 Dec; 26(1):918-927. PubMed ID: 31526064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular redox-activated anticancer drug delivery by functionalized hollow mesoporous silica nanoreservoirs with tumor specificity.
    Luo Z; Hu Y; Cai K; Ding X; Zhang Q; Li M; Ma X; Zhang B; Zeng Y; Li P; Li J; Liu J; Zhao Y
    Biomaterials; 2014 Sep; 35(27):7951-62. PubMed ID: 24930850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. pH-Sensitive mesoporous silica nanoparticles for chemo-photodynamic combination therapy.
    Yan T; Cheng J; Liu Z; Cheng F; Wei X; He J
    Colloids Surf B Biointerfaces; 2018 Jan; 161():442-448. PubMed ID: 29121617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyaluronic Acid-Functionalized Hollow Mesoporous Silica Nanoparticles as pH-Sensitive Nanocarriers for Cancer Chemo-Photodynamic Therapy.
    Zhou Y; Chang C; Liu Z; Zhao Q; Xu Q; Li C; Chen Y; Zhang Y; Lu B
    Langmuir; 2021 Mar; 37(8):2619-2628. PubMed ID: 33586432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous NO-release multi-responsive hollow mesoporous silica nanoparticles for drug encapsulation and delivery.
    Wu S; Shi J; Chen X; Bai L; Wu Q; Zhang G
    Colloids Surf B Biointerfaces; 2023 Jul; 227():113346. PubMed ID: 37230051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.